Leflunomide is used in the treatment of :
First, I need to recall what leflunomide is used for. From what I remember, leflunomide is an immunosuppressant, often used in autoimmune conditions. Specifically, I think it's used for rheumatoid arthritis. But wait, are there other uses? Maybe psoriasis? Let me double-check. Yes, leflunomide is approved for rheumatoid arthritis and psoriasis. So the question is asking which of the options are correct. The user's correct answer is probably C. Rheumatoid arthritis, assuming the options are something like that.
Core Concept: The main point here is the therapeutic use of leflunomide. It's a disease-modifying antirheumatic drug (DMARD) primarily for rheumatoid arthritis. It works by inhibiting dihydroorotate dehydrogenase, which is involved in pyrimidine synthesis. That's a key enzyme in the de novo pathway of pyrimidine synthesis, leading to suppression of T-cell proliferation.
Why Correct Answer is Right: Leflunomide inhibits DHODH, reducing the production of pyrimidines. This decreases T-cell activity, which is part of the immune response in rheumatoid arthritis. It's used to slow down joint damage and improve symptoms. So, the correct answer would be rheumatoid arthritis.
Wrong Options: Let's say the options are A. Psoriasis, B. Diabetes, C. Rheumatoid arthritis, D. Hypertension. Then B and D are definitely incorrect. Psoriasis is a possible correct use, but if the question is asking for the primary indication, rheumatoid arthritis is the main one. So if the options include both, maybe the correct answer is C, and A is an alternative. But the user's correct answer is given, so I need to align with that.
Clinical Pearl: Remember that leflunomide is a DMARD for RA and psoriasis. It's contraindicated in pregnancy due to teratogenic effects. Also, the drug has a long half-life, so a cholestyramine challenge is needed for discontinuation before pregnancy.
Putting it all together, the correct answer is C. Rheumatoid arthritis. The other options would be incorrect based on their relation to leflunomide's use. Need to make sure each section is concise and fits within the character limit.
**Core Concept**
Leflunomide is a disease-modifying antirheumatic drug (DMARD) primarily indicated for rheumatoid arthritis. It inhibits dihydroorotate dehydrogenase (DHODH), a key enzyme in pyrimidine synthesis, suppressing T-cell proliferation and reducing autoimmune inflammation.
**Why the Correct Answer is Right**
Leflunomide’s mechanism targets the de novo pyrimidine synthesis pathway, which is critical for T-cell activation. By inhibiting DHODH, it reduces T-cell-mediated immune responses, slowing joint damage in rheumatoid arthritis. Its efficacy in this condition is well-established, making it a first-line alternative to methotrexate when intolerance exists.
**Why Each Wrong Option is Incorrect**
**Option A